<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">

<pdf2xml>
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="0" size="22" family="Times" color="#000000"/>
	<fontspec id="1" size="8" family="Times" color="#000000"/>
	<fontspec id="2" size="7" family="Times" color="#000000"/>
<text top="23" left="55" width="517" height="33" font="0"><b>ENCODE DCC Antibody Validation Document</b></text>
<text top="77" left="48" width="81" height="12" font="1">Date of Submission</text>
<text top="347" left="39" width="41" height="12" font="1">Antibody </text>
<text top="359" left="39" width="52" height="12" font="1">Description: </text>
<text top="371" left="39" width="2" height="12" font="1"> </text>
<text top="485" left="84" width="61" height="12" font="1">Species Target</text>
<text top="521" left="84" width="90" height="12" font="1">Validation Method #1</text>
<text top="134" left="291" width="25" height="12" font="1">Email:</text>
<text top="134" left="48" width="27" height="12" font="1">Name:</text>
<text top="215" left="48" width="68" height="12" font="1">Antibody Name:</text>
<text top="215" left="300" width="29" height="12" font="1">Target:</text>
<text top="170" left="192" width="15" height="12" font="1">Lab</text>
<text top="249" left="183" width="44" height="12" font="1">Company/</text>
<text top="261" left="183" width="31" height="12" font="1">Source:</text>
<text top="485" left="300" width="53" height="12" font="1">Species Host</text>
<text top="300" left="336" width="50" height="12" font="1">Lot Number</text>
<text top="294" left="39" width="172" height="12" font="1">Catalog Number, database ID, laboratory </text>
<text top="306" left="39" width="2" height="12" font="1"> </text>
<text top="521" left="300" width="90" height="12" font="1">Validation Method #2</text>
<text top="555" left="84" width="50" height="12" font="1">Purification </text>
<text top="567" left="84" width="33" height="12" font="1">Method</text>
<text top="555" left="300" width="48" height="12" font="1">Polyclonal/ </text>
<text top="567" left="300" width="50" height="12" font="1">Monoclonal</text>
<text top="626" left="30" width="58" height="12" font="1">Reference (PI/</text>
<text top="638" left="30" width="49" height="12" font="1">Publication </text>
<text top="650" left="30" width="52" height="12" font="1">Information)</text>
<text top="674" left="28" width="294" height="12" font="1">Please complete the following for antibodies to histone modifications: </text>
<text top="687" left="28" width="205" height="11" font="2">if your specifications are not listed in the drop-down box,  </text>
<text top="697" left="28" width="155" height="11" font="2">please write-in the appropriate information</text>
<text top="728" left="30" width="59" height="12" font="1">Histone Name</text>
<text top="728" left="156" width="52" height="12" font="1">AA modified</text>
<text top="728" left="327" width="48" height="12" font="1">AA Position</text>
<text top="728" left="444" width="53" height="12" font="1">Modification</text>
<text top="419" left="39" width="29" height="12" font="1">Target </text>
<text top="431" left="39" width="52" height="12" font="1">Description: </text>
<text top="443" left="39" width="2" height="12" font="1"> </text>
<text top="599" left="165" width="51" height="12" font="1">Vendor URL:</text>
<text top="77" left="138" width="53" height="12" font="1">Sep 12, 2011</text>
<text top="359" left="94" width="354" height="12" font="1">Mouse monoclonal IgG2a; raised against recombinant TEF-3 (TEAD4) of human origin</text>
<text top="485" left="150" width="31" height="12" font="1">Human</text>
<text top="521" left="178" width="53" height="12" font="2">Western Blot</text>
<text top="134" left="326" width="102" height="12" font="1">fpauli@hudsonalpha.org</text>
<text top="134" left="83" width="61" height="12" font="1">Florencia Pauli</text>
<text top="215" left="121" width="83" height="12" font="1">TEAD4_(SC-101184)</text>
<text top="215" left="339" width="28" height="12" font="1">TEAD4</text>
<text top="170" left="230" width="25" height="12" font="1">Myers</text>
<text top="255" left="239" width="107" height="12" font="1">Santa Cruz Biotechnology</text>
<text top="485" left="361" width="28" height="12" font="1">Mouse</text>
<text top="300" left="395" width="27" height="12" font="1">A1811</text>
<text top="300" left="215" width="42" height="12" font="1">sc-101184</text>
<text top="521" left="395" width="54" height="12" font="2">IP-Mass Spec</text>
<text top="561" left="356" width="50" height="12" font="2">Monoclonal</text>
<text top="413" left="94" width="440" height="12" font="1">Member of the transcriptional enhancer factor (TEF) family of transcription factors, which contain the TEA/</text>
<text top="425" left="94" width="429" height="12" font="1">ATTS DNA-binding domain. It is preferentially expressed in the skeletal muscle, and binds to the M-CAT </text>
<text top="437" left="94" width="400" height="12" font="1">regulatory element found in promoters of muscle-specific genes to direct their gene expression. </text>
<text top="449" left="94" width="116" height="12" font="1">Entrez gene ID 7004; 48 kDa</text>
<text top="599" left="238" width="171" height="12" font="1">http://www.scbt.com/datasheet-101184-</text>
<text top="611" left="238" width="104" height="12" font="1">tef-3-n-g2-antibody.html</text>
</page>
<page number="2" position="absolute" top="0" left="0" height="792" width="612">
<text top="146" left="52" width="57" height="12" font="1">Validation #1 </text>
<text top="158" left="52" width="34" height="12" font="1">Analysis</text>
<text top="661" left="50" width="143" height="12" font="1">Insert Validation Image (click here)</text>
<text top="80" left="125" width="95" height="12" font="1">Western blot protocol: </text>
<text top="92" left="125" width="428" height="12" font="1">Whole cell lysate was immunoprecipitated using primary antibody, and the IP fraction was loaded on a </text>
<text top="104" left="125" width="422" height="12" font="1">12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. After separation, the samples </text>
<text top="116" left="125" width="422" height="12" font="1">were transferred to a nitrocellulose membrane with an Invitrogen iBlot system.  Blotting with primary </text>
<text top="128" left="125" width="422" height="12" font="1">(same as that used for IP) and secondary HRP-conjugated antibodies was performed on an Invitrogen </text>
<text top="140" left="125" width="414" height="12" font="1">BenchPro 4100 system. Visualization was achieved using SuperSignal West Femto solution (Thermo </text>
<text top="152" left="125" width="47" height="12" font="1">Scientific).  </text>
<text top="164" left="125" width="2" height="12" font="1"> </text>
<text top="176" left="125" width="346" height="12" font="1">Results: Band of expected size visualized, representing strongest signal in the lane.  </text>
<text top="188" left="125" width="2" height="12" font="1"> </text>
<text top="200" left="125" width="391" height="12" font="1">Figure legend: IP-western with sc-101184 in whole cell lysate (WCL) of K562, HepG2 and HeLa; </text>
<text top="212" left="125" width="202" height="12" font="1">PM=protein marker. TEAD4 bands are indicated. </text>
</page>
<page number="3" position="absolute" top="0" left="0" height="792" width="612">
<text top="159" left="57" width="57" height="12" font="1">Validation #2 </text>
<text top="171" left="57" width="34" height="12" font="1">Analysis</text>
<text top="643" left="54" width="145" height="12" font="1">Insert Validation Image (Click here)</text>
<text top="99" left="130" width="144" height="12" font="1">IP followed by mass spectrometry: </text>
<text top="111" left="130" width="419" height="12" font="1">Briefly, K562 whole cell lysates were immunoprecipitated using primary antibody, and the IP fraction </text>
<text top="123" left="130" width="402" height="12" font="1">was loaded on a 12% acrylamide gel and separated with a Bio-Rad PROTEAN II xi system. Gel was </text>
<text top="135" left="130" width="417" height="12" font="1">stained with Coomassie Blue in order to visualize marker bands. Gel fragments corresponding to the </text>
<text top="147" left="130" width="420" height="12" font="1">bands indicated above in the western blot image were excised and sent to the University of Alabama </text>
<text top="159" left="130" width="423" height="12" font="1">at Birmingham Cancer Center Mass Spectrometry/Proteomics Shared Facility. There the samples were </text>
<text top="171" left="130" width="423" height="12" font="1">run on an LTQ XL Linear Ion Trap Mass Spectrometer by LC-ESI-MS/MS. Peptides were identified using </text>
<text top="183" left="130" width="355" height="12" font="1">SEQUEST tandem mass spectra analysis, with probability based matching at p &lt; 0.05.  </text>
<text top="195" left="130" width="2" height="12" font="1"> </text>
<text top="207" left="130" width="268" height="12" font="1">As per ENCODE data standards, all SEQUEST results are attached </text>
<text top="219" left="130" width="399" height="12" font="1">(ENCODE_HAIB_TEAD4_sc101184_09222011_MassSpec.pdf), including common contaminants. </text>
<text top="231" left="130" width="221" height="12" font="1">Target protein is listed as hit 15a in the ~55kDa band.</text>
<text top="695" left="268" width="68" height="12" font="1">Submit by Email</text>
</page>
<page number="4" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="3" size="7" family="Times" color="#000000"/>
<text top="121" left="57" width="30" height="11" font="3"><b>Entry </b></text>
<text top="133" left="57" width="16" height="11" font="3"><b>no.</b></text>
<text top="109" left="93" width="40" height="11" font="3"><b>Protein </b></text>
<text top="121" left="93" width="39" height="11" font="3"><b>probabi</b></text>
<text top="133" left="93" width="16" height="11" font="3"><b>lity</b></text>
<text top="133" left="138" width="37" height="11" font="3"><b>Protein</b></text>
<text top="133" left="270" width="58" height="11" font="3"><b>Description</b></text>
<text top="145" left="56" width="6" height="11" font="2">1</text>
<text top="145" left="128" width="97" height="11" font="2">1 UniRef100_P49411</text>
<text top="145" left="270" width="164" height="11" font="2">Elongation factor Tu, mitochondrial </text>
<text top="157" left="56" width="6" height="11" font="2">2</text>
<text top="157" left="128" width="297" height="11" font="2">1 UniRef100_UPI0000111654 MONOCLONAL ANTIBODY MAK33 </text>
<text top="181" left="56" width="6" height="11" font="2">3</text>
<text top="181" left="128" width="136" height="11" font="2">1 UniRef100_UPI0001552F69</text>
<text top="169" left="270" width="278" height="11" font="2">PREDICTED: similar to [Human Ig rearranged gamma chain </text>
<text top="181" left="270" width="252" height="11" font="2">mRNA, V-J-C region and complete cds.], gene product </text>
<text top="193" left="56" width="11" height="11" font="2">5a</text>
<text top="193" left="128" width="100" height="11" font="2">1 UniRef100_A6NCC1</text>
<text top="193" left="270" width="243" height="11" font="2">Putative uncharacterized protein ENSP00000351411 </text>
<text top="217" left="56" width="11" height="11" font="2">6a</text>
<text top="217" left="128" width="99" height="11" font="2">1 UniRef100_A8K2X8</text>
<text top="205" left="270" width="277" height="11" font="2">cDNA FLJ78433, highly similar to Homo sapiens chaperonin </text>
<text top="217" left="270" width="240" height="11" font="2">containing TCP1, subunit 5 (epsilon) (CCT5), mRNA </text>
<text top="229" left="56" width="11" height="11" font="2">7a</text>
<text top="229" left="128" width="100" height="11" font="2">1 UniRef100_B1ANR0</text>
<text top="229" left="270" width="256" height="11" font="2">Poly(A) binding protein, cytoplasmic 4 (Inducible form) </text>
<text top="253" left="56" width="11" height="11" font="2">8a</text>
<text top="253" left="128" width="98" height="11" font="2">1 UniRef100_B2R6L0</text>
<text top="241" left="270" width="264" height="11" font="2">cDNA, FLJ93005, highly similar to Homo sapiens tubulin, </text>
<text top="253" left="270" width="151" height="11" font="2">beta polypeptide (TUBB), mRNA </text>
<text top="265" left="56" width="11" height="11" font="2">8b</text>
<text top="265" left="128" width="100" height="11" font="2">1 UniRef100_Q8IWP6</text>
<text top="265" left="270" width="104" height="11" font="2">Class IVb beta tubulin </text>
<text top="277" left="56" width="11" height="11" font="2">8c</text>
<text top="277" left="128" width="99" height="11" font="2">1 UniRef100_B3KS31</text>
<text top="277" left="270" width="146" height="11" font="2">Tubulin, beta 6, isoform CRA_a </text>
<text top="301" left="56" width="11" height="11" font="2">8d</text>
<text top="301" left="102" width="126" height="11" font="2">0.9995 UniRef100_B3KML9</text>
<text top="289" left="270" width="276" height="11" font="2">cDNA FLJ11352 fis, clone HEMBA1000020, highly similar to </text>
<text top="301" left="270" width="103" height="11" font="2">Tubulin beta-2C chain </text>
<text top="325" left="56" width="11" height="11" font="2">9a</text>
<text top="325" left="128" width="99" height="11" font="2">1 UniRef100_B2RA03</text>
<text top="313" left="270" width="276" height="11" font="2">cDNA, FLJ94640, highly similar to Homo sapiens keratin 18 </text>
<text top="325" left="270" width="76" height="11" font="2">(KRT18), mRNA </text>
<text top="337" left="56" width="17" height="11" font="2">10a</text>
<text top="337" left="128" width="100" height="11" font="2">1 UniRef100_B4DG54</text>
<text top="337" left="270" width="75" height="11" font="2">cDNA FLJ56635 </text>
<text top="361" left="56" width="17" height="11" font="2">11a</text>
<text top="361" left="128" width="100" height="11" font="2">1 UniRef100_B4DGL0</text>
<text top="349" left="270" width="282" height="11" font="2">cDNA FLJ53619, highly similar to Heat shock protein HSP 90-</text>
<text top="361" left="270" width="23" height="11" font="2">beta </text>
<text top="385" left="56" width="17" height="11" font="2">12a</text>
<text top="385" left="128" width="100" height="11" font="2">1 UniRef100_B4DTG2</text>
<text top="385" left="270" width="284" height="11" font="2">cDNA FLJ56389, highly similar to Elongation factor 1-gamma </text>
<text top="409" left="56" width="17" height="11" font="2">13a</text>
<text top="409" left="128" width="98" height="11" font="2">1 UniRef100_B4E2C5</text>
<text top="409" left="270" width="283" height="11" font="2">cDNA FLJ54032, highly similar to Elongation factor 1-alpha 1 </text>
<text top="421" left="56" width="17" height="11" font="2">14a</text>
<text top="421" left="128" width="100" height="11" font="2">1 UniRef100_C5IWV5</text>
<text top="421" left="270" width="58" height="11" font="2">Trypsinogen </text>
<text top="433" left="57" width="19" height="11" font="3"><b>15a</b></text>
<text top="433" left="127" width="114" height="11" font="3"><b>1 UniRef100_D3DUQ6</b></text>
<text top="433" left="270" width="236" height="11" font="3"><b>TEA domain family member 4, isoform CRA_b </b></text>
<text top="445" left="56" width="17" height="11" font="2">16a</text>
<text top="445" left="128" width="99" height="11" font="2">1 UniRef100_O60884</text>
<text top="445" left="270" width="175" height="11" font="2">DnaJ homolog subfamily A member 2 </text>
<text top="457" left="56" width="17" height="11" font="2">17a</text>
<text top="457" left="128" width="97" height="11" font="2">1 UniRef100_P02769</text>
<text top="457" left="270" width="73" height="11" font="2">Serum albumin </text>
<text top="469" left="56" width="17" height="11" font="2">18a</text>
<text top="469" left="128" width="97" height="11" font="2">1 UniRef100_P04264</text>
<text top="469" left="270" width="140" height="11" font="2">Keratin, type II cytoskeletal 1 </text>
<text top="481" left="56" width="17" height="11" font="2">18b</text>
<text top="481" left="128" width="97" height="11" font="2">1 UniRef100_P35908</text>
<text top="481" left="270" width="188" height="11" font="2">Keratin, type II cytoskeletal 2 epidermal </text>
<text top="493" left="56" width="16" height="11" font="2">18c</text>
<text top="493" left="128" width="97" height="11" font="2">1 UniRef100_P05787</text>
<text top="493" left="270" width="140" height="11" font="2">Keratin, type II cytoskeletal 8 </text>
<text top="505" left="56" width="17" height="11" font="2">18d</text>
<text top="505" left="128" width="96" height="11" font="2">1 UniRef100_B0YJC4</text>
<text top="505" left="270" width="88" height="11" font="2">Vimentin variant 3 </text>
<text top="517" left="56" width="17" height="11" font="2">19a</text>
<text top="517" left="128" width="97" height="11" font="2">1 UniRef100_P04424</text>
<text top="517" left="270" width="110" height="11" font="2">Argininosuccinate lyase </text>
<text top="529" left="56" width="17" height="11" font="2">20a</text>
<text top="529" left="128" width="97" height="11" font="2">1 UniRef100_P06576</text>
<text top="529" left="270" width="194" height="11" font="2">ATP synthase subunit beta, mitochondrial </text>
<text top="541" left="56" width="17" height="11" font="2">21a</text>
<text top="541" left="128" width="97" height="11" font="2">1 UniRef100_P06733</text>
<text top="541" left="270" width="68" height="11" font="2">Alpha-enolase </text>
<text top="553" left="56" width="17" height="11" font="2">22a</text>
<text top="553" left="128" width="97" height="11" font="2">1 UniRef100_P13645</text>
<text top="553" left="270" width="142" height="11" font="2">Keratin, type I cytoskeletal 10 </text>
<text top="565" left="56" width="17" height="11" font="2">22b</text>
<text top="565" left="128" width="97" height="11" font="2">1 UniRef100_P35527</text>
<text top="565" left="270" width="136" height="11" font="2">Keratin, type I cytoskeletal 9 </text>
<text top="577" left="56" width="16" height="11" font="2">22c</text>
<text top="577" left="128" width="97" height="11" font="2">1 UniRef100_P08727</text>
<text top="577" left="270" width="142" height="11" font="2">Keratin, type I cytoskeletal 19 </text>
<text top="589" left="56" width="17" height="11" font="2">22d</text>
<text top="589" left="107" width="118" height="11" font="2">0.997 UniRef100_P02533</text>
<text top="589" left="270" width="142" height="11" font="2">Keratin, type I cytoskeletal 14 </text>
<text top="601" left="56" width="17" height="11" font="2">23a</text>
<text top="601" left="128" width="97" height="11" font="2">1 UniRef100_P19474</text>
<text top="601" left="270" width="86" height="11" font="2">52 kDa Ro protein </text>
<text top="613" left="56" width="17" height="11" font="2">24a</text>
<text top="613" left="128" width="97" height="11" font="2">1 UniRef100_P31689</text>
<text top="613" left="270" width="175" height="11" font="2">DnaJ homolog subfamily A member 1 </text>
<text top="637" left="56" width="17" height="11" font="2">25a</text>
<text top="637" left="128" width="97" height="11" font="2">1 UniRef100_P52597</text>
<text top="625" left="270" width="263" height="11" font="2">Heterogeneous nuclear ribonucleoprotein F, N-terminally </text>
<text top="637" left="270" width="49" height="11" font="2">processed </text>
<text top="649" left="56" width="17" height="11" font="2">27a</text>
<text top="649" left="128" width="99" height="11" font="2">1 UniRef100_Q14240</text>
<text top="649" left="270" width="151" height="11" font="2">Eukaryotic initiation factor 4A-II </text>
<text top="661" left="56" width="17" height="11" font="2">28a</text>
<text top="661" left="128" width="99" height="11" font="2">1 UniRef100_Q562R1</text>
<text top="661" left="270" width="115" height="11" font="2">Beta-actin-like protein 2 </text>
<text top="673" left="56" width="17" height="11" font="2">29a</text>
<text top="673" left="128" width="100" height="11" font="2">1 UniRef100_Q59GV2</text>
<text top="673" left="270" width="227" height="11" font="2">RNA binding motif protein 14 variant (Fragment) </text>
<text top="685" left="56" width="12" height="11" font="2">31</text>
<text top="685" left="102" width="125" height="11" font="2">0.9876 UniRef100_B3KNL2</text>
<text top="685" left="270" width="169" height="11" font="2">RuvB-like 2 (E. coli), isoform CRA_d </text>
<text top="73" left="57" width="489" height="11" font="3"><b>Validation 2: TEAD4_(SC-101184)</b> IP-Mass Spec on 55 kDa band identified in IP-Western in Validation </text>
<text top="85" left="57" width="272" height="11" font="2">1.  Target protein is listed as hit 15a in the ~55kDa band.  </text>
</page>
<page number="5" position="absolute" top="0" left="0" height="792" width="612">
<text top="85" left="56" width="12" height="11" font="2">32</text>
<text top="85" left="102" width="129" height="11" font="2">0.9876 UniRef100_B4DEW9</text>
<text top="73" left="270" width="258" height="11" font="2">cDNA FLJ52478, highly similar to Eukaryotic translation </text>
<text top="85" left="270" width="128" height="11" font="2">initiation factor 3 subunit 5 </text>
<text top="97" left="56" width="12" height="11" font="2">33</text>
<text top="97" left="102" width="126" height="11" font="2">0.9876 UniRef100_B4DN45</text>
<text top="97" left="270" width="158" height="11" font="2">S-adenosylmethionine synthetase </text>
<text top="121" left="56" width="12" height="11" font="2">34</text>
<text top="121" left="102" width="125" height="11" font="2">0.9876 UniRef100_B4E0S6</text>
<text top="109" left="270" width="244" height="11" font="2">cDNA FLJ55635, highly similar to pre-mRNA-splicing </text>
<text top="121" left="270" width="254" height="11" font="2">factorATP-dependent RNA helicase DHX15 (EC 3.6.1.-) </text>
<text top="133" left="56" width="12" height="11" font="2">35</text>
<text top="133" left="102" width="126" height="11" font="2">0.9876 UniRef100_B5BUB5</text>
<text top="133" left="270" width="128" height="11" font="2">Autoantigen La (Fragment) </text>
<text top="145" left="56" width="12" height="11" font="2">36</text>
<text top="145" left="102" width="125" height="11" font="2">0.9876 UniRef100_O15160</text>
<text top="145" left="270" width="260" height="11" font="2">DNA-directed RNA polymerases I and III subunit RPAC1 </text>
<text top="157" left="56" width="12" height="11" font="2">37</text>
<text top="157" left="102" width="125" height="11" font="2">0.9876 UniRef100_Q14739</text>
<text top="157" left="270" width="83" height="11" font="2">Lamin-B receptor </text>
<text top="169" left="56" width="12" height="11" font="2">38</text>
<text top="169" left="102" width="126" height="11" font="2">0.9876 UniRef100_Q86U70</text>
<text top="169" left="270" width="139" height="11" font="2">LIM domain-binding protein 1 </text>
<text top="193" left="56" width="12" height="11" font="2">39</text>
<text top="193" left="102" width="125" height="11" font="2">0.9864 UniRef100_B4DTC3</text>
<text top="181" left="270" width="264" height="11" font="2">cDNA FLJ54150, highly similar to Heterogeneous nuclear </text>
<text top="193" left="270" width="99" height="11" font="2">ribonucleoprotein D0 </text>
<text top="205" left="56" width="12" height="11" font="2">40</text>
<text top="205" left="102" width="127" height="11" font="2">0.9864 UniRef100_Q53GN7</text>
<text top="205" left="270" width="259" height="11" font="2">Mitochondrial ribosomal protein S30 variant (Fragment) </text>
<text top="217" left="56" width="12" height="11" font="2">41</text>
<text top="217" left="102" width="123" height="11" font="2">0.9828 UniRef100_P17987</text>
<text top="217" left="270" width="160" height="11" font="2">T-complex protein 1 subunit alpha </text>
<text top="229" left="56" width="12" height="11" font="2">42</text>
<text top="229" left="102" width="126" height="11" font="2">0.9804 UniRef100_Q9BVP2</text>
<text top="229" left="270" width="193" height="11" font="2">Guanine nucleotide-binding protein-like 3 </text>
<text top="253" left="56" width="12" height="11" font="2">43</text>
<text top="253" left="102" width="127" height="11" font="2">0.9792 UniRef100_Q9NZC9</text>
<text top="241" left="270" width="244" height="11" font="2">SWI/SNF-related matrix-associated actin-dependent </text>
<text top="253" left="270" width="227" height="11" font="2">regulator of chromatin subfamily A-like protein 1 </text>
<text top="265" left="56" width="12" height="11" font="2">44</text>
<text top="265" left="107" width="120" height="11" font="2">0.978 UniRef100_A8K3D0</text>
<text top="265" left="270" width="75" height="11" font="2">cDNA FLJ75185 </text>
<text top="289" left="56" width="12" height="11" font="2">45</text>
<text top="289" left="107" width="119" height="11" font="2">0.978 UniRef100_B4DP56</text>
<text top="277" left="270" width="283" height="11" font="2">cDNA FLJ52237, highly similar to Creatine kinase B-type (EC </text>
<text top="289" left="270" width="40" height="11" font="2">2.7.3.2) </text>
<text top="301" left="56" width="12" height="11" font="2">46</text>
<text top="301" left="102" width="128" height="11" font="2">0.9768 UniRef100_B4DMC6</text>
<text top="301" left="270" width="245" height="11" font="2">cDNA FLJ60696, highly similar to Elongation factor 2 </text>
<text top="325" left="56" width="12" height="11" font="2">47</text>
<text top="325" left="102" width="126" height="11" font="2">0.9708 UniRef100_A6NK07</text>
<text top="325" left="270" width="286" height="11" font="2">Eukaryotic translation initiation factor 2 subunit 2-like protein </text>
<text top="337" left="56" width="12" height="11" font="2">48</text>
<text top="337" left="102" width="123" height="11" font="2">0.9626 UniRef100_P00762</text>
<text top="337" left="270" width="81" height="11" font="2">Anionic trypsin-1 </text>
<text top="349" left="56" width="12" height="11" font="2">49</text>
<text top="349" left="102" width="122" height="11" font="2">0.9504 UniRef100_C9JAF0</text>
<text top="349" left="270" width="243" height="11" font="2">Putative uncharacterized protein ENSP00000391831 </text>
</page>
</pdf2xml>
